Why Jennifer Doudna is one of Fast Company’s 10 most innovative people of the last 10 years

Doudna codeveloped the revolutionary gene-editing technology known as CRISPR-Cas9. Now it’s leading to cures to some of the world’s most intractable diseases.

This story is part of a special series celebrating the 10th anniversary of the Fast Company Innovation Festival.